Biofilms contribute to the development of hospital-acquired infection

Liz Meszaros, MDLinx

Superbugs and Superdrugs USA

Iselin, New Jersey, United States | November 13-14, 2017


Iselin, NJ, November 14, 2017--Polymicrobial biofilm allows for horizontal gene transfer and the development of new multi-drug resistant strains of bacteria, but the role of these biofilms in spreading hospital-acquired infections has long been overlooked, according to Carl Genberg, BSc, JD, CEO, N8 Medical, LLC, Las Vegas, NV.

CeraShield is an investigational coating for endotracheal tubes and other indwelling medical devices that is highly effective at preventing bacterial biofilms. First-in-human studies of this compound are planned for the first half of 2018, and the FDA has designated it as a "breathrough device" pursuant to the 21st Century Cures Act in April 2017.